Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-006315
Filing Date
2025-08-14
Accepted
2025-08-14 16:05:44
Documents
50
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q voyageracq_10q.htm   iXBRL 10-Q 622862
2 EXHIBIT 31.1 voyageracq_ex31-1.htm EX-31.1 8307
3 EXHIBIT 31.2 voyageracq_ex31-2.htm EX-31.2 8664
4 EXHIBIT 32.1 voyageracq_ex32-1.htm EX-32.1 3953
  Complete submission text file 0001829126-25-006315.txt   3398485

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vachu-20250630.xsd EX-101.SCH 33430
6 XBRL CALCULATION FILE vachu-20250630_cal.xml EX-101.CAL 26574
7 XBRL DEFINITION FILE vachu-20250630_def.xml EX-101.DEF 166888
8 XBRL LABEL FILE vachu-20250630_lab.xml EX-101.LAB 189957
9 XBRL PRESENTATION FILE vachu-20250630_pre.xml EX-101.PRE 190060
52 EXTRACTED XBRL INSTANCE DOCUMENT voyageracq_10q_htm.xml XML 500622
Mailing Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002
Business Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002 03477204333
Voyager Acquisition Corp./Cayman Islands (Filer) CIK: 0002006815 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42211 | Film No.: 251218807
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)